IBD Masterclass: Choosing the Right IBD Therapy - A Patient-Clinician Connection
Florence Odufalu, MD
Ugo Iroku, MD, MHS
Beyond One-Size-Fits-All: Individualizing First-Line IBD Treatment
Michael Dolinger, MD, MBA
The Evolving Role of Small Molecules in IBD Care
David T. Rubin, MD
The Future of Biologic Treatment in IBD: What’s on the Horizon
Small Molecules in IBD: JAK Inhibitors and S1P Modulators
Translating Advances into Practice: Lessons from Today’s IBD Landscape
Targeting Inflammation in IBD: Localized vs Systemic Strategies
IBD Beyond Symptoms: What Community GIs Need to Know
Understanding the Microbiome’s Role in IBD Management
Genetic Susceptibility in IBD: From Risk Genes to Clinical Impact
Pathophysiology of IBD: The War Within
Tailoring Treatment: Can You Select the Best Therapy?
David Rubin, MD
Brooke Hodnick, PA-C, MPAS
Switching Strategies: Switch or Stay—What’s Your Call?
Treat-to-Target: Are We There Yet?
Kimberly D. Orleck, PA-C
Jennifer Geremia, PA-C
Case Review: Targets Are Met—Can You Stick the Landing?
2024 IBD Pharmacist Virtual Symposium
Loading...
We're glad to see you're enjoying Crohn's Colitis Professional… but how about a more personalized experience?
Press cancel to remain on Crohn's Colitis Professional. Press the link below or the continue button to keep going.